Search

Robert E. Mosser

Examiner (ID: 16617, Phone: (571)272-4451 , Office: P/3714 )

Most Active Art Unit
3715
Art Unit(s)
3714, 3715, 3713, 3712
Total Applications
839
Issued Applications
347
Pending Applications
141
Abandoned Applications
372

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 12247283 [patent_doc_number] => 09920049 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-03-20 [patent_title] => 'Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection' [patent_app_type] => utility [patent_app_number] => 15/349343 [patent_app_country] => US [patent_app_date] => 2016-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 25120 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15349343 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/349343
Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection Nov 10, 2016 Issued
Array ( [id] => 11618233 [patent_doc_number] => 20170128421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-11 [patent_title] => 'Premix formulation for parenteral use and packaging thereof' [patent_app_type] => utility [patent_app_number] => 15/348374 [patent_app_country] => US [patent_app_date] => 2016-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6189 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15348374 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/348374
Premix formulation for parenteral use and packaging thereof Nov 9, 2016 Abandoned
Array ( [id] => 16244789 [patent_doc_number] => 10744113 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-08-18 [patent_title] => Use of chromone derivative as pharmaceutical composition for prevention and treatment of fibrosis using EMT inhibitory activity [patent_app_type] => utility [patent_app_number] => 15/347795 [patent_app_country] => US [patent_app_date] => 2016-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 9293 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15347795 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/347795
Use of chromone derivative as pharmaceutical composition for prevention and treatment of fibrosis using EMT inhibitory activity Nov 9, 2016 Issued
Array ( [id] => 13504545 [patent_doc_number] => 20180303815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-25 [patent_title] => COMBINATION OF BCL-2 INHIBITOR AND MEK INHIBITOR FOR THE TREATMENT OF CANCER [patent_app_type] => utility [patent_app_number] => 15/767914 [patent_app_country] => US [patent_app_date] => 2016-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16412 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15767914 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/767914
Combination of Bcl-2 inhibitor and MEK inhibitor for the treatment of cancer Nov 2, 2016 Issued
Array ( [id] => 11441848 [patent_doc_number] => 20170042869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-16 [patent_title] => 'Methods for limiting acute kidney injury' [patent_app_type] => utility [patent_app_number] => 15/334770 [patent_app_country] => US [patent_app_date] => 2016-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5304 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15334770 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/334770
Methods for limiting acute kidney injury Oct 25, 2016 Abandoned
Array ( [id] => 11554161 [patent_doc_number] => 20170100400 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-13 [patent_title] => 'INHIBITORS OF INFLUENZA VIRUSES REPLICATION' [patent_app_type] => utility [patent_app_number] => 15/299757 [patent_app_country] => US [patent_app_date] => 2016-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 115 [patent_figures_cnt] => 115 [patent_no_of_words] => 207834 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15299757 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/299757
Inhibitors of influenza viruses replication Oct 20, 2016 Issued
Array ( [id] => 11441878 [patent_doc_number] => 20170042900 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-16 [patent_title] => 'PREVENTIVE AND/OR THERAPEUTIC AGENT OF IMMUNE DISEASE' [patent_app_type] => utility [patent_app_number] => 15/297196 [patent_app_country] => US [patent_app_date] => 2016-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 42910 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15297196 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/297196
Preventive and/or therapeutic agent of immune disease Oct 18, 2016 Issued
Array ( [id] => 11401692 [patent_doc_number] => 20170022227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-26 [patent_title] => 'CRYSTALLIZATION METHOD AND BIOAVAILABILITY' [patent_app_type] => utility [patent_app_number] => 15/288139 [patent_app_country] => US [patent_app_date] => 2016-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 70944 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15288139 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/288139
Crystallization method and bioavailability Oct 6, 2016 Issued
15/283422 5-SUBSTITUTED 2, 4-THIAZOLIDINEDIONES (THIOHYDANTOINS), PSEUDOTHIOHYDANTOINS, AND PROPSEUDOTHIOHYDANTOINS FOR USE AS ANTIVIRAL AND ANTIFUNGAL AGENTS Oct 1, 2016 Abandoned
Array ( [id] => 11381482 [patent_doc_number] => 20170007538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-12 [patent_title] => 'INJECTION PREPARATION AND METHOD FOR PRODUCING THE SAME' [patent_app_type] => utility [patent_app_number] => 15/269989 [patent_app_country] => US [patent_app_date] => 2016-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14093 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15269989 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/269989
Injection preparation and method for producing the same Sep 19, 2016 Issued
Array ( [id] => 13674995 [patent_doc_number] => 20160376231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-29 [patent_title] => ANTIVIRAL COMPOUNDS AND METHODS [patent_app_type] => utility [patent_app_number] => 15/262075 [patent_app_country] => US [patent_app_date] => 2016-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7867 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15262075 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/262075
Antiviral compounds and methods Sep 11, 2016 Issued
Array ( [id] => 13635179 [patent_doc_number] => 09844539 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-12-19 [patent_title] => Compounds and methods for kinase modulation, and indications therefor [patent_app_type] => utility [patent_app_number] => 15/260042 [patent_app_country] => US [patent_app_date] => 2016-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35631 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15260042 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/260042
Compounds and methods for kinase modulation, and indications therefor Sep 7, 2016 Issued
Array ( [id] => 12171011 [patent_doc_number] => 09889127 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-02-13 [patent_title] => 'Method of inhibiting mutant C-KIT' [patent_app_type] => utility [patent_app_number] => 15/255912 [patent_app_country] => US [patent_app_date] => 2016-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 5555 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15255912 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/255912
Method of inhibiting mutant C-KIT Sep 1, 2016 Issued
Array ( [id] => 11455849 [patent_doc_number] => 20170049751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-23 [patent_title] => 'OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/254271 [patent_app_country] => US [patent_app_date] => 2016-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 31199 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15254271 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/254271
OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF Aug 31, 2016 Abandoned
Array ( [id] => 13383813 [patent_doc_number] => 20180243448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-30 [patent_title] => DEVICES, KITS, AND METHODS FOR DETERMINING INEFFECTIVENESS OF ANESTHETICS [patent_app_type] => utility [patent_app_number] => 15/755127 [patent_app_country] => US [patent_app_date] => 2016-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5187 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -69 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15755127 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/755127
DEVICES, KITS, AND METHODS FOR DETERMINING INEFFECTIVENESS OF ANESTHETICS Aug 25, 2016 Abandoned
Array ( [id] => 11362791 [patent_doc_number] => 20170000772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-05 [patent_title] => 'SMALL MOLECULE MODULATORS OF PRB INACTIVATION' [patent_app_type] => utility [patent_app_number] => 15/237801 [patent_app_country] => US [patent_app_date] => 2016-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14081 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15237801 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/237801
SMALL MOLECULE MODULATORS OF PRB INACTIVATION Aug 15, 2016 Abandoned
Array ( [id] => 13672467 [patent_doc_number] => 20160374967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-29 [patent_title] => ORGANIC THIOPHOSPHATE ANTIRETROVIRAL AGENTS [patent_app_type] => utility [patent_app_number] => 15/235847 [patent_app_country] => US [patent_app_date] => 2016-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14105 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15235847 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/235847
ORGANIC THIOPHOSPHATE ANTIRETROVIRAL AGENTS Aug 11, 2016 Abandoned
Array ( [id] => 11421214 [patent_doc_number] => 20170029359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-02 [patent_title] => 'ANTIMICROBIAL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 15/234592 [patent_app_country] => US [patent_app_date] => 2016-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 15662 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15234592 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/234592
ANTIMICROBIAL COMPOUNDS Aug 10, 2016 Abandoned
Array ( [id] => 15571449 [patent_doc_number] => 10576083 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-03-03 [patent_title] => Method of treating pulmonary arterial hypertension [patent_app_type] => utility [patent_app_number] => 15/230803 [patent_app_country] => US [patent_app_date] => 2016-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3748 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15230803 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/230803
Method of treating pulmonary arterial hypertension Aug 7, 2016 Issued
Array ( [id] => 13165555 [patent_doc_number] => 10098869 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-10-16 [patent_title] => Compounds for the treatment of cancers associated with human papillomavirus [patent_app_type] => utility [patent_app_number] => 15/231684 [patent_app_country] => US [patent_app_date] => 2016-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 8919 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15231684 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/231684
Compounds for the treatment of cancers associated with human papillomavirus Aug 7, 2016 Issued
Menu